No Data
MiMedx Group Initiated at Overweight by Cantor Fitzgerald
MiMedx Group Initiated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Initiates Coverage On MiMedx Group With Overweight Rating, Announces Price Target of $11
Cantor Fitzgerald analyst Ross Osborn initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Overweight rating and announces Price Target of $11.
Cantor Fitzgerald Initiates MiMedx(MDXG.US) With Buy Rating, Announces Target Price $11
Cantor Fitzgerald analyst Ross Osborn initiates coverage on $MiMedx(MDXG.US)$ with a buy rating, and sets the target price at $11.According to TipRanks data, the analyst has a success rate of 18.1% an
Express News | MiMedx Announces the Appointment of Kim Moller to Chief Commercial Officer
With 45% Ownership, MiMedx Group, Inc. (NASDAQ:MDXG) Has Piqued the Interest of Institutional Investors
Wound Skin Substitutes Market Global Analysis to 2030, Featuring Coloplast, Smith & Nephew, MTF Biologics, MiMedx, AlloSource, Organogenesis, RTI Surgical, LifeNet Health and Molecular Biologicals